<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-C6T831ZA/2d4554f4-bef4-4010-84ff-82aec0f0a23e/PDF"><dcterms:extent>219 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-C6T831ZA/e8844882-b118-40ef-a19c-f92f969ccbdd/TEXT"><dcterms:extent>54 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-C6T831ZA"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2018</dcterms:issued><dc:creator>Burja, Blaž</dc:creator><dc:creator>Čučnik, Saša</dc:creator><dc:creator>Hočevar, Alojzija</dc:creator><dc:creator>Ješe, Rok</dc:creator><dc:creator>Lakota, Katja</dc:creator><dc:creator>Praprotnik, Sonja</dc:creator><dc:creator>Rotar, Žiga</dc:creator><dc:creator>Sodin-Šemrl, Snežna</dc:creator><dc:creator>Tomšič, Matija</dc:creator><dc:creator>Žigon, Polona</dc:creator><dc:format xml:lang="sl">številka:7/8</dc:format><dc:format xml:lang="sl">letnik:87</dc:format><dc:format xml:lang="sl">str. 335-348</dc:format><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID_HOST:33943001</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-C6T831ZA</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">biološki označevalci</dc:subject><dc:subject xml:lang="en">biomarkers</dc:subject><dc:subject xml:lang="en">early giant cell arteritis</dc:subject><dc:subject xml:lang="sl">tarčno zdravljenje</dc:subject><dc:subject xml:lang="en">therapy targets</dc:subject><dc:subject xml:lang="sl">zgodnji gigantocelični arteritis</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Zgodnji gigantocelični arteritis| as od simptomov do diagnoze, možnosti zdravljenja in klinično značilna celična dinamika| Early giant cell arteritis| identifying duration from symptoms to diagnosis, possible therapies and clinically-relevant cell dynamics|</dc:title><dc:description xml:lang="sl">Giant cell arteritis (GCA) is the most prevalent primary systemic vasculitis in adults over 50 ye - ars of age in Europe. It affects large and medium sized arteries; the inflammatory process can ultimately lead to stenosis or occlusion of arterial lumen, resulting in severe clinical complica- tions. In the last decade, imaging in diagnostics has importantly shortened the time to disease recognition (e.g. early GCA). Fast track clinics have led to a decrease in appearance of the most severe ischemic disease complications and lower costs of therapy. Despite fast access to approp - riate therapy, the disease is chronic, and patients can experience relapses, which together with glucocorticoid therapy may lead to organ and tissue damage. Therefore, viable molecular and cellular target therapies are intensely explored. The major aims of our review were to: a) identify studies with indicated time from symptom development to diagnosis, b) explore promising molecular targets for GCA therapy, and c) identify clinically-relevant cellular phenotypes. The most promising molecular targets are IL-6, IL-12/IL-23, cytotoxic T-lymphocyte-associated protein-4, while therapies against TNF-alpha showed limited value and no clinical studies with secukimumab targeting IL-17 in GCA have been reported to date. Potential future therapeutic targets have been discussed, including targets in signaling pathways</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-C6T831ZA"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-C6T831ZA" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-C6T831ZA/2d4554f4-bef4-4010-84ff-82aec0f0a23e/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-C6T831ZA/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-C6T831ZA" /></ore:Aggregation></rdf:RDF>